
In statin-treated PCI patients with LDL <70, inflammation, not TG, gave ~1.8x more MACE
A shared study summary: among more than 9,400 statin-treated PCI patients with LDL under 70 mg/dL, elevated hs-CRP (2 mg/L or more) carried about 1.8x higher MACE risk, whereas elevated triglycerides alone showed no significant increase. Louis frames inflammation as a major driver of residual risk.
